Ofra Levy-Hacham
Direttore Tecnico/Scientifico/R&S presso SOL-GEL TECHNOLOGIES LTD.
Profilo
Ofra Levy-Hacham is currently the VP-Clinical & Regulatory Affairs at Sol-Gel Technologies Ltd.
He previously worked as the Head-Quality Assurance at Savient Pharmaceuticals, Inc. and as the Vice President-Chemistry & Manufacturing Control at HealOr Ltd.
from 2005 to 2010.
He also served as the Head-Drug Discovery at Geffen Residence & Renewal Ltd.
and as a Project Manager at Biotechnology General (Israel) Ltd.
from 2010 to 2011.
Dr. Levy-Hacham holds a doctorate degree from Technion-Israel Institute of Technology.
Posizioni attive di Ofra Levy-Hacham
Società | Posizione | Inizio |
---|---|---|
SOL-GEL TECHNOLOGIES LTD. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Precedenti posizioni note di Ofra Levy-Hacham
Società | Posizione | Fine |
---|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | 01/01/2011 |
HealOr Ltd.
HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Corporate Officer/Principal | 01/01/2010 |
SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | - |
GEFFEN RESIDENCE & RENEWAL LTD | Corporate Officer/Principal | - |
Formazione di Ofra Levy-Hacham
Technion-Israel Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GEFFEN RESIDENCE & RENEWAL LTD | Process Industries |
SOL-GEL TECHNOLOGIES LTD. | Health Technology |
Aziende private | 3 |
---|---|
HealOr Ltd.
HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Health Technology |
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
- Borsa valori
- Insiders
- Ofra Levy-Hacham